India detects total 71 cases of the new UK mutant strain

The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG labs.

PTI
January 06, 2021 / 01:31 PM IST

Representative image: (Image: Reuters)

The number of people who have tested positive for the new UK variant of SARS-CoV-2 in the country has climbed to 71, the Union Health Ministry said on Wednesday. These 71 cases include the 58 which were announced by the ministry till Tuesday.

"The total number of cases infected with the new strain of the novel coronavirus first reported in the UK now stands at 71," the ministry said.

All these persons have been kept in single room isolation in designated Health Care facilities by respective state governments, the ministry had said on Tuesday.

Their close contacts have also been put under quarantine. Comprehensive contact tracing has been initiated for co-travellers, family contacts and others. Genome sequencing on other specimens is going on, the ministry said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The situation is under careful watch and regular advice is being provided to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG labs.

The presence of the new UK variant has already been reported by several countries including Denmark, the Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore.

The Government of India took cognizance of the reports of virus reported from the UK and put in place a proactive and preventive strategy to detect and contain the mutant variant, it said.

This strategy includes temporary suspension of all flights coming from the UK with effect from the midnight of December 23 till January 7 and mandatory testing of all UK-returned air passengers through RT-PCR test.

The samples of all UK returnees found positive in RT-PCR test will be genome sequenced by a consortium of 10 government labs i.e. INSACOG.

All the international passengers who have arrived in India between December 9 and 22, if symptomatic and tested positive for COVID-19 will be subjected to genome sequencing as part of the Centre's strategy to detect the mutated UK variant in them.

Others will be followed up by the respective state and district surveillance officers and will be tested as per ICMR guidelines (even if asymptomatic)between 5th and 10th day, according to the Union Health Ministry's guidance document on genomic sequencing.

Epidemiological surveillance of the passengers, who have arrived in India since November 23 will be conducted in the community through active follow up.

Besides, standard operating protocol for states and UTs to tackle the mutant variant of SARS-CoV-2 was issued on December 22.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #Current Affairs #Health #Health Ministry #India
first published: Jan 6, 2021 01:21 pm